| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.30B | 1.49B | 1.66B | 1.64B | 1.33B |
| Gross Profit | 305.02M | 369.08M | 418.77M | 411.71M | 338.00M |
| EBITDA | 45.28M | 84.34M | 94.53M | 96.59M | 78.74M |
| Net Income | 17.67M | 49.69M | 56.05M | 54.20M | 41.98M |
Balance Sheet | |||||
| Total Assets | 483.40M | 506.73M | 472.30M | 470.44M | 400.63M |
| Cash, Cash Equivalents and Short-Term Investments | 67.96M | 69.76M | 83.20M | 65.81M | 57.53M |
| Total Debt | 84.45M | 39.87M | 29.02M | 34.13M | 35.09M |
| Total Liabilities | 248.31M | 258.08M | 249.42M | 270.05M | 242.48M |
| Stockholders Equity | 235.10M | 248.64M | 222.88M | 200.39M | 158.15M |
Cash Flow | |||||
| Free Cash Flow | 56.21M | 32.85M | 67.83M | 41.26M | 34.27M |
| Operating Cash Flow | 59.60M | 39.68M | 76.04M | 44.93M | 36.92M |
| Investing Cash Flow | -8.63M | -13.17M | -8.21M | -3.67M | -2.65M |
| Financing Cash Flow | -52.49M | -39.92M | -52.15M | -38.54M | -24.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £13.50M | 3.24 | 24.41% | 6.40% | -6.12% | 4.30% | |
71 Outperform | £35.32M | 5.49 | 11.07% | 3.35% | 2.40% | 1101.69% | |
69 Neutral | £185.73M | 12.17 | 7.83% | 6.35% | -13.93% | -48.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
48 Neutral | £423.83M | 81.54 | 4.18% | 7.58% | -12.54% | -76.55% | |
46 Neutral | £55.78M | -3.34 | -24.67% | 12.88% | -14.31% | -361.93% | |
45 Neutral | £507.25M | 748.65 | -2.24% | 1.76% | -4.92% | -58.06% |